Search
Returning search results with filters:
Remove filter for
Issue: Health products
Remove filter for
Last updated: 2019
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
- (-) 2019
- December 201918 results available
- November 201911 results available
- October 201925 results available
- September 201923 results available
- August 201915 results available
- July 201921 results available
- June 201919 results available
- May 201914 results available
- April 201915 results available
- March 201917 results available
- February 201910 results available
- January 20196 results available
Recall class
Displaying 121 - 135 of 194 items.
Galantamine ER (2019-06-19)
RecallHealth product recall | 2019-06-19
DermaZinc Spray (2019-06-18)
RecallHealth product recall | 2019-06-18
Health Canada warns Canadians of potential cancer risk associated with gentian violet
AlertInformation update | 2019-06-12
Labelling error may lead to patients receiving Linessa 28 birth control pills instead of Linessa 21
AlertPublic advisory | 2019-06-12
Thrive Gentian Ear Wash (2019-06-12)
RecallHealth product recall | 2019-06-12
Konsar Future Nutrition Products Recall (2019-06-10)
RecallHealth product recall | 2019-06-10
Fake Viagra seized from Adult Store in Scarborough, Ontario, may pose serious health risks
AlertPublic advisory | 2019-06-10
Betadine Sore Throat Gargle (2019-06-04)
RecallHealth product recall | 2019-06-05
Oxyvet 100 LP (2019-06-04)
RecallHealth product recall | 2019-06-04
Blu Kote Dr. Naylors (2019-06-04)
RecallHealth product recall | 2019-06-04
Docetaxel Injection USP (2019-06-03)
RecallHealth product recall | 2019-06-03
Antimony Sulfide Colloid Kit (2019-06-03)
RecallHealth product recall | 2019-06-03
Important Safety Information on Alaris Infusion Sets and Alaris 8100 Pump Module - Risk of Over-Infusion
AlertHealth professional risk communication | 2019-05-30
Health products manufactured by Konsar Future Nutrition Inc. may pose serious health risks
AlertInformation update | 2019-05-29
Health Canada suspends Allergan's licences for its Biocell breast implants after safety review concludes an increased risk of cancer
AlertInformation update | 2019-05-28